Skip to main content

Advertisement

Fig. 3 | BMC Cancer

Fig. 3

From: Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review

Fig. 3

PET CT scan images showing changes in metabolic activity at the site of recurrent tumor after starting treatment with concurrent radiotherapy and immunotherapy. (a) and (c) illustrate a high standardized uptake values (SUV) in sagittal and axial sections respectively. It decreased in next 12 weeks following therapy as indicated by relatively decreased metabolic activity of tumor in sagittal (b) and axial sections (d)

Back to article page